LifeSan Clinical Research undergoes unannounced successful inspection from US FDA EP News Bureau Dec 20, 2019 There were no 483 observations LifeSan Clinical Research, a division of Centaur Pharmaceuticals recently underwent an…
LifeSan Clinical Research receives zero 483 observations from US FDA EP News Bureau Sep 10, 2019 The observation signifies compliance and conformance to applicable GCP regulations LifeSan Clinical Research, the clinical…
